anemia
The patient was instructed in hemolytic anemia the need to evade aspects that quick hemolytic emergency like infection, trauma, chemicals, and toxic drug reactions. The patient was advised the need for a well-balanced diet that is rich in iron and protein. The patient was reviewed to evade fatty foods. The patient was recommended to maintain hydration position.
The patient was instructed in iron deficiency anemia that stools will appear dark or black as the effect of iron additional treatment. The patient was advised the importance of checking for blood loss in the stool if has gastrointestinal bleeding predispositions. The patient was taught the correct use of guaiac exams. The patient was reviewed to take iron with meals to make best use of absorption. The patient was recommended the need to increase vitamin C consumption.
Caregiver/A.L.F's staff was instructed in different patient's symptoms of anemia , which can include cognitive dysfunction, headaches, dizziness, nervousness, lack of concentration, forgetfulness, fatigue amounts others.
Ferrous sulfate 325 is used to treat iron deficiency anemia (a lack of red blood cells caused by having too little iron in the body). Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
The medication Procrit is used to treat anemia(low red blood cell count) in people with long-term serious kidney disease ,people receiving chemotherapy for some types of cancer. It may also used in anemic patient to reduce the need for blood transfusions. Procrit works by signaling the bone marrow to make more red blood cells.
Instructed in factors that contribute to poor skin integrity such as immobilization, poor circulation, moisture, heat, anemia, shearing forces, poor nutritional status.
Instructed in new medication Bextra to manage osteoarthritis. In addition. warned of possible S/E such as dizziness, headache, cerebrovascular disorder, peripheral edema, hypertension, angina pectoris, arrhythmia, heart failure, aneurysm, sinusitis, abdominal fullness, abdominal pain, diarrhea, dyspepsia, flatulence, nausea, renal impairment, thrombocytopenia, leukopenia, anemia, hepatitis, hyperglycemia, hypercholesterolemia, hyperkalemia, hyperlipidemia, hyperuricemia, hypocalcemia, hypokalemia, increased or decreased weight, back pain, myalgia, upper respiratory tract infection, bronchospasm, rash, flu-like syndrome, accidental injury.
Instructed in new medication Cozaar and in S/E such as dizziness, asthenia, fatigue, headache, insomnia, edema, chest pain, nasal congestion, sinusitis, pharyngitis, sinus disorder, abdominal pain, nausea, diarrhea, dyspepsia, muscle cramps, myalgia, back or leg pain, cough, upper respiratory infection, angioedema, asthenia, fatigue, fever, hypesthesia, chest pain, hypotension, orthostatic hypotension, sinusitis, cataract, diarrhea, dyspepsia, gastritis, urinary tract infection, anemia, hyperkalemia, hypoglycemia, weight gain, back pain, leg or knee pain, muscle weakness, cough, bronchitis, cellulites and others.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Feroso to manage anemia. In addition, warned of possible S/E such as nausea, vomiting, constipation, GI discomfort, headache, dizziness, dry mouth, rash and others.